Method of modulating factor D, factor H and CD4 cell immune response with a polystyrene sulfonate, alginate, and saline infusion solution
OwnerKumarpal A. Shahinventor
Life of this patent
Estimating the term…
Abstract
Anthrax bio-terrorism is a poor man's nuclear bomb with devastating effects on the freedom and economy of any nation. No nation is immune. Urgently, there is a need for life saving technology that can be readily available and deployed in real time. Polystyrene sulfonate is the answer. It is life saving and will help in the development of next generation superior vaccines.
Claims14
A method of modulating an immune response in a host induced by pathogens comprising the steps of:
- providing polystyrene sulfonate in a dose of 5-10 mg per kg of body weight of the mammal;
- infusing the polystyrene sulfonate in a saline solution to form a polystyrene sulfonate infusion;
- dissolving ultra purified alginate into the polystyrene sulfonate infusion to form a polystyrene sulfonate and alginate infusion;
- and
- administering the polystyrene sulfonate and alginate infusion intravenously to the mammal, wherein the polystyrene sulfonate and alginate infusion provides immune modulation action on Factor D, Factor H and CD4 cells in the mammal.
A method of suppressing negative pathology caused by acute onset of complement system activation in a mammal exposed to pathogens, said pathogens releasing at least one of exotoxins and endotoxins in the mammal, and stimulating immune responses in said mammal, the method comprising the steps of:
- providing a mixture of different size fractionations of polystyrene sulfonate in a dose of 5-10 mg per kg of body weight of the mammal;
- infusing the mixture of polystyrene sulfonate in a saline solution to form a polystyrene sulfonate infusion;
- dissolving ultra purified alginate into the polystyrene sulfonate infusion to form a polystyrene sulfonate and alginate infusion;
- and
- administering the polystyrene sulfonate and alginate infusion intravenously to the mammal, wherein the polystyrene sulfonate and alginate infusion provides therapeutic immune modulation action on Factor D, Factor H and CD4 cells for inhibiting the acute complement system activation and stimulating immune responses in the mammal.
Dependencies are inferred from the claim text.